The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Lipoprotein Lipase Links Dietary Fat to Solid Tumor Cell Proliferation
Open accessPublished version of a preprint
Abstract
Many types of cancer cells require a supply of fatty acids (FA) for growth and survival, and interrupting de novo FA synthesis in model systems causes potent anticancer effects. We hypothesized that, in addition to synthesis, cancer cells may obtain preformed, diet-derived FA by uptake from the bloodstream. This would require hydrolytic release of FA from triglyceride in circulating lipoprotein particles by the secreted enzyme lipoprotein lipase (LPL), and the expression of CD36, the channel for cellular FA uptake. We find that selected breast cancer and sarcoma cells express and secrete active LPL, and all express CD36. We further show that LPL, in the presence of triglyceride-rich lipoproteins, accelerates the growth of these cells. Providing LPL to prostate cancer cells, which express low levels of the enzyme, did not augment growth, but did prevent the cytotoxic effect of FA synthesis inhibition. Moreover, LPL knockdown inhibited HeLa cell growth. In contrast to the cell lines, immunohistochemical analysis confirmed the presence of LPL and CD36 in the majority of breast, liposarcoma, and prostate tumor tissues examined (n = 181). These findings suggest that, in addition to de novo lipogenesis, cancer cells can use LPL and CD36 to acquire FA from the circulation by lipolysis, and this can fuel their growth. Interfering with dietary fat intake, lipolysis, and/or FA uptake will be necessary to target the requirement of cancer cells for FA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An elevated expression of lipoprotein lipase (LPL) and monoacylglycerol lipase (MAGL) across diverse cancer subtypes and correlates with invasiveness”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Kuemmerle et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
[19] Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
Goldstein, J. L., Basu, S. K., & Brown, M. S. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)98152-1 · Cited by 1,629
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002
Research works printed but not linked: 2
- Weiss, 1986, Fatty-acid biosynthesis in man, a pathway of minor importance, J Biol Chem, 367, 905
- Parlo, 1984, Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria, J Biol Chem, 259.
Cited by
Sorted by citations
Items 101–200 of 287
Li, B., Mi, J., & Yuan, Q. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02126-9 · Cited by 50
Mable, C. J., Cantón, I., Mykhaylyk, O. O., Gul, B. U., Chambon, P., Themistou, E., & Armes, S. P. (2019) · Chemical Science · doi:10.1039/c8sc05589k · Cited by 45
Feng, W. W., & Kurokawa, M. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.100 · Cited by 44
Sharma, M., Arora, I., Chen, M., Wu, H., Crowley, M. R., Tollefsbol, T. O., & Li, Y. (2021) · Nutrients · doi:10.3390/nu13113944 · Cited by 40
Lipid metabolism in tumor microenvironment: novel therapeutic targets
Liu, X., Zhang, P., Xu, J., Lv, G., & Li, Y. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02645-4 · Cited by 39
The effects of conjugated linoleic acids on breast cancer: A systematic review
Arab, A., Akbarian, S. A., Ghiyasvand, R., & Miraghajani, M. S. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.185573 · Cited by 40
Henderson, F., Johnston, H. R., Badrock, A. P., Jones, E. A., Forster, D. M., Nagaraju, R. T., Evangelou, C., Kamarashev, J. A., Green, M., Fairclough, M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2409 · Cited by 42
Tian, C., Guo, J., Wang, G., Sun, B., Na, K., Zhang, X., Xu, Z., Cheng, M., He, Z., & Sun, J. (2019) · Advanced Science · doi:10.1002/advs.201901810 · Cited by 39
Luanpitpong, S., Janan, M., Thumanu, K., Poohadsuan, J., Rodboon, N., Klaihmon, P., & Issaragrisil, S. (2019) · Cancers · doi:10.3390/cancers11040576 · Cited by 39
Hofmanová, J., Slavík, J., Cigánek, M., Ovesná, P., Tylichová, Z., Karasová, M., Zapletal, O., Straková, N., Procházková, J., Bouchal, J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136650 · Cited by 39
The Heterogeneity of Lipid Metabolism in Cancer
Park, J. K., Coffey, N. J., Limoges, A., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_3 · Cited by 38
Lipidomics as a Diagnostic Tool for Prostate Cancer
Buszewska‐Forajta, M., Pomastowski, P., Monedeiro, F., Walczak‐Skierska, J., Markuszewski, M., Matuszewski, M., Markuszewski, M. J., & Buszewski, B. (2021) · Cancers · doi:10.3390/cancers13092000 · Cited by 36
Chan, S., Tsai, J.-P., Shen, C., Liao, Y.-H., & Chen, B. (2017) · Oncotarget · doi:10.18632/oncotarget.17326 · Cited by 36
BEclear: Batch Effect Detection and Adjustment in DNA Methylation Data
Akulenko, R., Merl, M., & Helms, V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159921 · Cited by 34
Role of Lipoproteins in the Microenvironment of Hormone-Dependent Cancers
Gomaraschi, M. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.11.005 · Cited by 35
Seo, J., Kim, K.-S., Park, J., Cho, J., Chang, H., Fukuda, J., Hong, K. Y., & Chun, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120622 · Cited by 33
Liu, Y., Li, C., Fang, L., Wang, L., Liu, H., Tian, H., Zheng, Y., Fan, T. T., & He, J. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.944 · Cited by 32
Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma
Bobulescu, I. A., Pop, L. M., Mani, C., Turner, K., Rivera, C., Khatoon, S., Kairamkonda, S., Hannan, R., & Palle, K. (2021) · Metabolites · doi:10.3390/metabo11090608 · Cited by 32
Capulli, M., Angelucci, A., Driouch, K., Garcia, T., Clément-Lacroix, P., Martella, F., Ventura, L., Bologna, M., Flamini, S., Moreschini, O., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1686 · Cited by 31
The metabolic landscape of urological cancers: New therapeutic perspectives
Miranda‐Gonçalves, V., Lameirinhas, A., Henrique, R., Baltazar, F., & Jerónimo, C. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.034 · Cited by 33
Huang, M., Narita, S., Koizumi, A., Nara, T., Numakura, K., Satoh, S., Nanjo, H., & Habuchi, T. (2021) · 癌症:英文版 · doi:10.1002/cac2.12137 · Cited by 31
Metabolic Remodeling Induced by Adipocytes: A New Achilles' Heel in Invasive Breast Cancer?
Attané, C., Milhas, D., Hoy, A. J., & Muller, C. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180426165001 · Cited by 32
Dembitz, V., James, S. C., & Gallipoli, P. (2025) · Leukemia · doi:10.1038/s41375-025-02645-z · Cited by 33
Fatty acids: Adiposity and breast cancer chemotherapy, a bad synergy?
Mentoor, I., Engelbrecht, A., & Nell, T. A. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.11.009 · Cited by 28
Huang, W., Liang, Y., & Ma, X. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0869-z · Cited by 31
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma
Danilova, O. V., Dumont, L. J., Levy, N. B., Lansigan, F., Kinlaw, W. B., Danilov, A. V., & Kaur, P. (2012) · Journal of Hematopathology · doi:10.1007/s12308-012-0166-4 · Cited by 29
Liu, R., & Godbout, R. (2020) · Cancers · doi:10.3390/cancers12123823 · Cited by 29
New insights into lipid metabolism and prostate cancer (Review)
Zhang, Z., Wang, W., Kong, P., Feng, K., Liu, C., Sun, T., Sang, Y., Duan, X., Tao, Z., & Liu, W. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5522 · Cited by 37
Mahalingam, D., Harb, W. A., Patnaik, A., Bullock, A. J., Watnick, R. S., Vincent, M. Y., Chen, J., Wang, S., Pestana, H. R., Chao, J., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00433-x · Cited by 28
Transcriptional regulatory networks in human lung adenocarcinoma
MENG, X., Lü, P., BAI, H., XIAO, P., & Fan, Q. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1034 · Cited by 28
Lupien, L. E., Dunkley, E. M., Maloy, M. J., Lehner, I. B., Foisey, M. G., Ouellette, M. E., Lewis, L. D., Pooler, D. B., Kinlaw, W. B., & Baures, P. W. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258947 · Cited by 27
Cancer cell lipid class homeostasis is altered under nutrient-deprivation but stable under hypoxia
Lisec, J., Jaeger, C., Rashid, R., Munir, R., & Zaidi, N. (2019) · BMC Cancer · doi:10.1186/s12885-019-5733-y · Cited by 27
The dysfunctional lipids in prostate cancer.
Dang, Q., Chen, Y., & Hsieh, J. (2019) · PubMed Central · Cited by 25
EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
Wang, Z., Chao, Z., Wang, Q., Zou, F., Song, T., Xu, L., Ning, J., & Fan, C. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04822-z · Cited by 24
Rodríguez-Razón, C. M., Yañez-Sánchez, I., RAMOS-SANTILLAN, V. O., Velásquez-Ordoñez, C., Gutiérrez-Rubio, S. A., García-García, M. R., López-Roa, R. I., Sánchez-Hernández, P. E., Daneri‐Navarro, A., & García‐Iglesias, T. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s152237 · Cited by 25
Activation of CD44-Lipoprotein lipase axis in breast cancer stem cells promotes tumorigenesis
Manupati, K., Yeeravalli, R., Kaushik, K., Singh, D., Mehra, B., Gangane, N., Gupta, A. P., Goswami, K., & Das, A. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166228 · Cited by 24
Poddar, A., Rao, S. R., Prithviraj, P., Kannourakis, G., & Jayachandran, A. (2022) · Current Oncology · doi:10.3390/curroncol29100540 · Cited by 24
Xiao, J., Cao, S., Wang, J., Li, P., Cheng, Q., Zhou, X., Dong, J., Li, Y., Zhao, X., Xu, Z., et al. (2024) · 癌症:英文版 · doi:10.1002/cac2.12583 · Cited by 23
The Correlation between Lipid Metabolism Disorders and Prostate Cancer
Dłubek, J., Rysz, J., Jabłonowski, Z., Gluba-Brzózka, A., & Franczyk, B. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200806103744 · Cited by 23
Prieto, D., & Oppezzo, P. (2017) · Molecules · doi:10.3390/molecules22122083 · Cited by 23
Ta, N. L., & Seyfried, T. N. (2015) · Lipids · doi:10.1007/s11745-015-4075-z · Cited by 24
Precision nutrition to target lipid metabolism alterations in cancer
de Cedrón, M. G., & de Molina, A. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819178-1.00028-9 · Cited by 23
Importance of lactate dehydrogenase (LDH) and monocarboxylate transporters (MCTs) in cancer cells
Hatami, H., Sajedi, A., Mir, S. M., & Memar, M. Y. (2022) · Health Science Reports · doi:10.1002/hsr2.996 · Cited by 21
Khan, S. A., Faisal, A., Mpindi, J. P., Parkkinen, J., Kalliokoski, T., Poso, A., Kallioniemi, O., Wennerberg, K., & Samuel Kaski, A. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-112 · Cited by 19
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression
Łaźniewska, J., Li, K. L., Johnson, I. R., Sorvina, A., Logan, J. M., Martini, C., Moore, C. R., Ung, B. S. ‐., Karageorgos, L., Hickey, S. M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40347-7 · Cited by 22
Storniolo, C. E., Cabral, M., Busquets, M. A., Martín-Venegas, R., & Moreno, J. J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.529976 · Cited by 20
Dyslipidemia in Chinese Pancreatic Cancer Patients: A Two-Center Retrospective Study
Wang, F., Huang, L., Zhang, J., Fan, J., Wu, H., & Xu, J. (2021) · Journal of Cancer · doi:10.7150/jca.60340 · Cited by 20
Wiggs, A., Molina, S., Sumner, S., & Rushing, B. R. (2022) · Nutrients · doi:10.3390/nu14101990 · Cited by 19
The Role of Dyslipidemia in Colitis-Associated Colorectal Cancer
Chen, K., Guo, J., Zhang, T., Gu, J., Li, H., & Wang, J. (2021) · Journal of Oncology · doi:10.1155/2021/6640384 · Cited by 17
Yu, H., Liu, Y., Pan, W., Shen, S., & Das, U. N. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.50962 · Cited by 18
Corona, G., Gregorio, E. D., Vignoli, A., Muraro, E., Steffan, A., & Miolo, G. (2021) · Cancers · doi:10.3390/cancers13225845 · Cited by 18
Resina, L., Garrudo, F. F. F., Alemán, C., Esteves, T., & Ferreira, F. C. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.213830 · Cited by 18
A Forgotten Corner in Cancer Immunotherapy: The Role of Lipids
Yu, Y., Gao, L., Wang, Y., Xu, B., Maswikiti, E. P., Li, H., Peng, Z., Tao, P., Xiang, L., Gu, B., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.751086 · Cited by 18
Metabolic syndrome and breast cancer: an overview.
Gezgen, G., Roach, E. C., Kızılarslanoğlu, M. C., Petekkaya, İ., & Altundağ, K. (2012) · PubMed · Cited by 18
de Wiele, C. V., Vlaenderen, M. V., D’hulst, L., Delcourt, A., Copin, D., Spiegeleer, B. M. J. D., & Maes, A. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3525-z · Cited by 18
An Overview on Lipid Droplets Accumulation as Novel Target for Acute Myeloid Leukemia Therapy
Nisticò, C., & Chiarella, E. (2023) · Biomedicines · doi:10.3390/biomedicines11123186 · Cited by 17
The macroenviromental control of cancer metabolism by p62
Huang, J., Díaz-Meco, M. T., & Moscat, J. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1520566 · Cited by 18
Zhao, L., Zhao, H., Wei, X., Guo, F., Wei, J., Wang, H., Yang, J. T., Yang, Z., Si, N., & Bian, B. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112943 · Cited by 17
Revisiting the dyslipidemia associated with acute leukemia
Usman, H., Rashid, R., Ameer, F., Iqbal, A., Zaid, M., Hasnain, S., Kalbacher, H., & Zaidi, N. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.038 · Cited by 16
Uptake of DNA by cancer cells without a transfection reagent
Kong, Y., Zhang, X., Zhao, Y., Xue, Y., & Ye, Z. (2017) · Biological Research · doi:10.1186/s40659-017-0107-x · Cited by 16
Derveaux, E., Thomeer, M., Mesotten, L., Reekmans, G., & Adriaensens, P. (2021) · Metabolites · doi:10.3390/metabo11080537 · Cited by 16
Imaging of cancer lipid metabolism in response to therapy
Arlauckas, S. P., Browning, E. A., Poptani, H., & Delikatny, E. J. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4070 · Cited by 15
Cellular reprogramming, chemoresistance, and dietary interventions in breast cancer
Pereira, I. C., Mascarenhas, I. F., Capetini, V. C., Ferreira, P. M. P., Rogero, M. M., & Torres‐Leal, F. L. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103796 · Cited by 17
da Cunha, P. A., Nițușcă, D., do Canto, L. M., Varghese, R. S., Ressom, H. W., Willey, S. C., Marian, C., & Haddad, B. R. (2022) · Metabolites · doi:10.3390/metabo12050447 · Cited by 14
Tripathi, V., Jaiswal, P., Verma, R., Sahu, K., Majumder, S. K., Chakraborty, S., Jha, H. C., & Parmar, H. S. (2023) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2023.100110 · Cited by 15
Xu, M., Xie, P., Liu, S., Gao, X., Yang, S., Hu, Z., Zhao, Y., Yi, Y., Dong, Q., Bruns, C. J., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217469 · Cited by 14
Valença, I., Ferreira, A., Correia, M., Kühl, S., van Roermund, C. W. T., Waterham, H. R., Máximo, V., Islinger, M., & Ribeiro, D. (2020) · Cancers · doi:10.3390/cancers12113152 · Cited by 14
Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications
Rombout, A., Verhasselt, B., & Philippé, J. (2016) · European Journal Of Haematology · doi:10.1111/ejh.12789 · Cited by 14
Ni, M., Liu, X., Meng, Z., Liu, S., Jia, S., Liu, Y., Zhou, W., Wu, J., Zhang, J., Guo, S., et al. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02939-y · Cited by 14
Bavis, M. M., Nicholas, A. M., Tobin, A. J., Christian, S., & Brown, R. J. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13559 · Cited by 10
Kobelyatskaya, A. A., Pudova, E. A., Katunina, I. V., Snezhkina, A. V., Fedorova, M., Pavlov, V., Kotelnikova, A. O., Nyushko, K. М., Alekseev, B. Y., Krasnov, G. S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119282 · Cited by 13
Wang, Y., Zhao, Z., Guo, T., Wu, T., Zhang, M., Luo, D., Dou, K., Yang, Y., Jin, C., Zhang, B., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00545-6 · Cited by 13
Lee, Y., Ni, J., Wasinger, V. C., Graham, P., & Li, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015462 · Cited by 13
Lu, J.-B., Cai, S., Pan, Y.-H., & Yun, J. (2018) · Cancer Management and Research · doi:10.2147/cmar.s181555 · Cited by 13
Chrzanowska, A., Olejarz, W., Kubiak-Tomaszewska, G., Ciechanowicz, A. K., & Struga, M. (2022) · Cancers · doi:10.3390/cancers14020409 · Cited by 13
Redox and metabolic reprogramming in breast cancer and cancer‐associated adipose tissue
Zakić, T., Pekovic‐Vaughan, V., Čvoro, A., Korać, A., Janković, A., & Korać, B. (2023) · FEBS Letters · doi:10.1002/1873-3468.14794 · Cited by 15
Bordanaba-Florit, G., Royo, F., Albóniga, O. E., Clayton, A., Falcón‐Pérez, J. M., & Webber, J. P. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167229 · Cited by 12
Tobin, A. J., Noel, N. P., Christian, S. L., & Brown, R. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05728-z · Cited by 12
Bovine Colostrum Treatment of Specific Cancer Types: Current Evidence and Future Opportunities
Alsayed, A. R., Hasoun, L., Khader, H. A., Basheti, I. A., & Permana, A. D. (2022) · Molecules · doi:10.3390/molecules27248641 · Cited by 12
Non-Coding and Regulatory RNAs as Epigenetic Remodelers of Fatty Acid Homeostasis in Cancer
Cruz-Gil, S., Fernández, L. P., Sánchez‐Martínez, R., de Cedrón, M. G., & de Molina, A. R. (2020) · Cancers · doi:10.3390/cancers12102890 · Cited by 12
Huang, G., Zhang, M., Wang, M., Xu, W., Duan, X., Han, X., & Ren, J. (2024) · Oncology Letters · doi:10.3892/ol.2024.14294 · Cited by 11
Serum metabolomic profile of hair dye use
Lim, J., Huang, J., Weinstein, S. J., Parisi, D., Männistö, S., & Albanes, D. (2023) · Scientific Reports · doi:10.1038/s41598-023-30590-3 · Cited by 11
LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR?
Cariello, M., Ducheix, S., Maqdasy, S., Baron, S., Moschetta, A., & Lobaccaro, J. A. (2018) · Nuclear Receptor Signaling · doi:10.1177/1550762918801070 · Cited by 12
Biological Mechanisms for the Effect of Obesity on Cancer Risk: Experimental Evidence
Díaz, M. B., Herzig, S., & Schafmeier, T. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42542-9_12 · Cited by 11
Replenishment of TCA cycle intermediates and long-noncoding RNAs regulation in breast cancer
Zheng, X., Zhang, S., Ma, H., Dong, Y., Zheng, J., Zeng, L., Liu, J., Dai, Y., & Yin, Q. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112321 · Cited by 10
Sun, J., Liu, J., Chen, F., Wang, X., & Wu, G. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2445774 · Cited by 12
Garbis, S. D., & Townsend, P. A. (2013) · Expert Review of Proteomics · doi:10.1586/14789450.2013.827408 · Cited by 9
The Relationship Between Hematological Neoplasms and Lipid Profile
Öztürk, E. (2021) · Medeniyet Medical Journal · doi:10.5222/mmj.2021.91145 · Cited by 10
Söylemez, B., Bulut, Z., & Bölükbaşı, S. Ş. (2022) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2022.0091 · Cited by 10
Zhang, M., Miao, Y., Zhao, C., Liu, T., Wang, X., Wang, Z., Zhong, W., He, Z., Tian, C., & Sun, J. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.100908 · Cited by 12
Progress in therapeutic strategies based on cancer lipid metabolism
Diao, X., & Lin, T. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13146 · Cited by 9
Diao, B., Fan, Z., Zhou, B., & Zhan, H. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151012 · Cited by 9
Attenuation of obesity-induced hyperlipidemia reduces tumor growth
Hussain, A., Lian, J., Watts, R., Gutiérrez, T., Nelson, R., Goping, I. S., & Lehner, R. S. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159124 · Cited by 9
Vitisin B as a novel fatty acid synthase inhibitor induces human breast cancer cells apoptosis.
Wang, X., Jiang, B., Lv, H., Liang, Y., & Ma, X. (2019) · Europe PMC (PubMed Central) · Cited by 7
Saha, A., Hamilton‐Reeves, J. M., & DiGiovanni, J. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10056-0 · Cited by 8
Alberto, M., Yim, A., Lawrentschuk, N., & Bolton, D. M. (2023) · Cancers · doi:10.3390/cancers15020341 · Cited by 7
Zuo, Q., Wu, Y., Hu, Y., Shao, C., Liang, Y., Chen, L., Guo, Q., Ping, H., & Chen, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30807 · Cited by 7
Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia
Mátrai, Z., Andrikovics, H., Szilvási, A., Bors, A., Kozma, A., Ádám, E., Halm, G., Karászi, É., Tordai, A., & Masszi, T. (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0132-z · Cited by 7
Yoneten, K. K., Kasap, M., Arğa, K. Y., Akpınar, G., & Utkan, N. Z. (2021) · Cancer Biomarkers · doi:10.3233/cbm-203093 · Cited by 7
Liu, Z.-M., Yang, M., Shu, H., & Zhou, J. (2023) · Translational Cancer Research · doi:10.21037/tcr-23-628 · Cited by 7
Metadata
- Authors
- Kuemmerle, N. B., Rysman, E., Lombardo, P. S., Flanagan, A. J., Lipe, B. C., Wells, W. A., Pettus, J. R., Froehlich, H. M., Memoli, V. A., Morganelli, P. M., Swinnen, J. V., Timmerman, L. A., Chaychi, L., Fricano, C. J., Eisenberg, B. L., Coleman, W. B., & Kinlaw, W. B.
- Affiliations
- Dartmouth–Hitchcock Medical Center (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Kinlaw, William B.
- ORCID
- Venue
- Molecular Cancer Therapeutics
- Published
- 2011-03-01
- Volume
- 10
- Issue
- 3
- Pages
- 427-436
- ISSN
- 1535-7163 (ISSN-L)
- 1538-8514
- PMC
- PMC3074101
- OpenAlex
- W2117594441
- Cited by
- 286
- References
- 46
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 22 · 2023: 20 · 2022: 31 · 2021: 35 · 2020: 24 · 2019: 32 · 2018: 19 · 2017: 16 · 2016: 21 · 2015: 11 · 2014: 9 · 2013: 8 · 2012: 11
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Cancer Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- Howard Hughes Medical Institute (52005870)
- Dartmouth College
- Fonds Wetenschappelijk Onderzoek
- Universität Ulm
- Vlaamse regering
- Norris Cotton Cancer Center
- National Cancer Institute (R01CA126618, P50CA058207, P30CA023108)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007508, DK 07508)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- lipoprotein lipase, CD36, fatty acid uptake, dietary fat, solid tumor growth, lipolysis, triglyceride-rich lipoproteins, breast cancer, sarcoma, prostate cancer, fatty acid synthesis inhibition, cancer metabolism
- MeSH terms
- Animals, Dietary Fats, Fatty Acids, Female, Humans, Lipolysis, Lipoprotein Lipase, Liposarcoma, Male, Mice, Transgenic, Neoplasms, CD36 Antigens, Oligonucleotide Array Sequence Analysis, RNA, Small Interfering, Cell Line, Tumor, Cell Proliferation, Mice, Fatty Acid Synthesis Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review